Atrial Fibrillation Symptoms and Pain Sensitization
Primary Purpose
Atrial Fibrillation
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Quantitative sensory testing
Sponsored by
About this trial
This is an interventional health services research trial for Atrial Fibrillation focused on measuring Atrial Fibrillation, Symptoms, Quality of Life, Pain, Conditioning pain modulation, Temporal summation
Eligibility Criteria
Inclusion Criteria:
- Male or female subjects 20 to 75 years old
- Permanent AF
- Previously completed AF-6
- Written informed consent
Exclusion Criteria:
- Paroxysmal or persistent AF
- Previous pulmonary vein isolation
- Psychiatric or cognitive condition
- Pregnancy
- Previous/current drug or alcohol abuse
- Previous neurological or concomitant musculoskeletal condition
- Continuous analgesic medication
Sites / Locations
- Department of cardiology
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Symptomatic patients
Asymptomatic patients
Arm Description
Subjects with symptoms of atrial fibrillation i.e. AF-6 sum score 30 points or more.
Subjects with no symptoms of atrial fibrillation i.e. AF-6 sum score = 0.
Outcomes
Primary Outcome Measures
Differences in pain sensitization
A handheld pressure algometer will be used to assess the pressure pain thresholds over the sternum and the tibialis anterior muscle. Low pressure pain thresholds indicate sensitization. A pin prick will be used to induce temporal summation of pressure pain. Ten consecutive stimuli will be applied over the sternum and tibialis anterior muscle and the patient will be asked to rate the pain intensity on the visual analogue scale (minimum 0, maximum 10, higher scores mean worse pain). Temporal summation of pressure pain will be calculated as the difference in the pain intensity between the first and the last stimulation. High temporal summation of pressure pain scores indicate facilitated temporal summation. The conditioning pain modulation index will be assessed as the increase in pain pressure thresholds during cold pressure test. The lower the difference is, the more sensitization.
Secondary Outcome Measures
Correlation of age, sex, AF duration and comorbidities and HRQoL to pain sensitization
Full Information
NCT ID
NCT04649437
First Posted
September 24, 2020
Last Updated
February 17, 2021
Sponsor
Region Örebro County
Collaborators
Aalborg University
1. Study Identification
Unique Protocol Identification Number
NCT04649437
Brief Title
Atrial Fibrillation Symptoms and Pain Sensitization
Official Title
Pain Sensitization in Patients With Symptomatic Atrial Fibrillation Compared With Asymptomatic Patients
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
November 26, 2020 (Actual)
Primary Completion Date
January 14, 2021 (Actual)
Study Completion Date
January 14, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Region Örebro County
Collaborators
Aalborg University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Atrial fibrillation (AF) is the most common sustained arrhythmia and the number of patients with AF is expected to increase substantially in the coming decades. One third of patients with AF report no AF-associated symptoms, but up to one fourth report severe symptoms such as chest pain. It is well recognized, but unclear why patients' experience of AF-related symptoms, including chest pain, varies so much. Patients with chronic pain show a high degree of central sensitization, i.e. facilitated pain responses to repeated painful stimulation and impaired conditioned pain modulation, compared with controls. It is possible that patients with symptomatic AF may have developed pronounced pain sensitization even in the absence of chest pain as a symptom. No previous study has investigated pain sensitization in patients with AF.
The primary objective is to assess differences in pain sensitization in patients with symptomatic AF compared with patients with asymptomatic AF. Secondary objectives are to study the association of age, sex, AF duration, comorbidities and health-related quality of life to pain sensitization. A total of 30 patients with permanent AF (15 symptomatic and 15 asymptomatic) will be recruited. Patients will complete an AF-specific symptom score and a generic health-related quality of life questionnaire, and physicians will assess AF-related symptoms. Quantitative sensory testing recordings will be collected by pressure algometry. Assessment of temporal summation of pressure pain and conditioning pain modulation will be used to investigate the involvement of pain sensitization.
This preliminary pilot study will be used to estimate sample size for a larger study in which both patients and control subjects will be recruited, to further investigate whether patients with symptomatic AF have increased pain sensitization compared with patients with asymptomatic AF and controls. The studies may have an impact on individualized management of patients with AF in the future.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation
Keywords
Atrial Fibrillation, Symptoms, Quality of Life, Pain, Conditioning pain modulation, Temporal summation
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Non-Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Symptomatic patients
Arm Type
Other
Arm Description
Subjects with symptoms of atrial fibrillation i.e. AF-6 sum score 30 points or more.
Arm Title
Asymptomatic patients
Arm Type
Other
Arm Description
Subjects with no symptoms of atrial fibrillation i.e. AF-6 sum score = 0.
Intervention Type
Diagnostic Test
Intervention Name(s)
Quantitative sensory testing
Intervention Description
Quantitative sensory testing recordings will be collected by pressure algometry Assessment of temporal summation of pressure pain and conditioning pain modulation will be used to investigate the involvement of pain sensitization.
Primary Outcome Measure Information:
Title
Differences in pain sensitization
Description
A handheld pressure algometer will be used to assess the pressure pain thresholds over the sternum and the tibialis anterior muscle. Low pressure pain thresholds indicate sensitization. A pin prick will be used to induce temporal summation of pressure pain. Ten consecutive stimuli will be applied over the sternum and tibialis anterior muscle and the patient will be asked to rate the pain intensity on the visual analogue scale (minimum 0, maximum 10, higher scores mean worse pain). Temporal summation of pressure pain will be calculated as the difference in the pain intensity between the first and the last stimulation. High temporal summation of pressure pain scores indicate facilitated temporal summation. The conditioning pain modulation index will be assessed as the increase in pain pressure thresholds during cold pressure test. The lower the difference is, the more sensitization.
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
Correlation of age, sex, AF duration and comorbidities and HRQoL to pain sensitization
Time Frame
Day 1
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female subjects 20 to 75 years old
Permanent AF
Previously completed AF-6
Written informed consent
Exclusion Criteria:
Paroxysmal or persistent AF
Previous pulmonary vein isolation
Psychiatric or cognitive condition
Pregnancy
Previous/current drug or alcohol abuse
Previous neurological or concomitant musculoskeletal condition
Continuous analgesic medication
Facility Information:
Facility Name
Department of cardiology
City
Örebro
ZIP/Postal Code
70185
Country
Sweden
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The study protocol, statistical analysis plan and informed consent form was shared with Dennis Boye Larsen and Lars Arendt Nielsen in Aalborg, Denmark in a meeting in person in September 2020. The clinical study report and encoded data regarding patient characteristics and results from questionnaires, body charts and quantitative sensory testing was shared with Dennis Boye Larsen and Lars Arendt Nielsen in Aalborg, Denmark, for statistical analysis. Data was made available by an encrypted usb flash drive sent by post. There is no other plan to make individual participant data available to other researchers.
IPD Sharing Time Frame
The encoded individual participant data is available for Dennis Boye Larsen and Lars Arendt Nielsen from 14th January 2021 to the end of march 2021.
Citations:
PubMed Identifier
34140311
Citation
Jackson A, Frobert O, Boye Larsen D, Arendt-Nielsen L, Bjorkenheim A. Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation. Open Heart. 2021 Jun;8(1):e001699. doi: 10.1136/openhrt-2021-001699.
Results Reference
derived
Learn more about this trial
Atrial Fibrillation Symptoms and Pain Sensitization
We'll reach out to this number within 24 hrs